Twist Bioscience (TWST) Inventory (2018 - 2026)

Twist Bioscience (TWST) has reported Inventory for 9 consecutive years, with $33.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Inventory rose 60.67% year-over-year to $33.5 million; the TTM figure through Mar 2026 stood at $33.5 million (up 60.67% YoY), while the FY2025 annual figure was $28.3 million, up 17.57% from the prior year.
• Inventory climbed to $33.5 million in Q1 2026 per TWST's latest filing, from $32.9 million in the prior quarter.
• Across five years, Inventory topped out at $44.6 million in Q4 2022 and bottomed at $20.9 million in Q1 2025.
• Historically, Inventory has averaged $32.9 million across 5 years, with a median of $32.1 million in 2023.
• Annual changes were most pronounced in 2022 — Inventory jumped 181.54% — and 2025, when it tumbled 31.33%.
• Twist Bioscience's Inventory stood at $44.6 million in 2022, then plunged by 30.8% to $30.9 million in 2023, then slipped by 23.8% to $23.5 million in 2024, then jumped by 39.99% to $32.9 million in 2025, then advanced by 1.8% to $33.5 million in 2026.
• Business Quant data shows TWST's Inventory at $33.5 million in Q1 2026, $32.9 million in Q4 2025, and $28.3 million in Q3 2025.